AbbVie

New drug approval is a win for the Bay State's horse in the hepatitis C race
Bizjournals.com
Tue, 07/28/15 - 12:34 pm
Enanta Pharmaceuticals
AbbVie
Technivie
hepatitis C
AbbVie, Bristol-Myers get FDA nod for hep C treatments
Yahoo/Reuters
Fri, 07/24/15 - 05:40 pm
AbbVie
Bristol-Myers Squibb
hepatitis C
FDA
Technivie
Daklinza
AbbVie reports first revenue miss in six quarters
Yahoo/Reuters
Fri, 07/24/15 - 10:07 am
AbbVie
earnings
What to Expect From AbbVie Earnings
Yahoo/24 7 Wall St
Thu, 07/23/15 - 11:05 pm
AbbVie
earnings
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Wed, 07/22/15 - 08:36 am
Pfizer
M&A
Hospira
AbbVie
Pharmacyclics
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Express Scripts
Bristol-Myers Squibb
Opdivo
FDA grants AbbVie's anti-tau drug orphan status
BioPharma Dive
Mon, 07/20/15 - 11:07 am
FDA
AbbVie
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
C2N Diagnostics
6 Big-Cap Drugmakers Reporting Earnings Next Week
Investors.com
Sat, 07/18/15 - 11:00 am
earnings
Novartis
Bristol-Myers Squibb
Eli Lilly
Valeant Pharmaceuticals
AbbVie
Biogen
3 Top Big Pharmaceutical Stocks With Upcoming Catalysts
24/7 Wall St
Tue, 07/14/15 - 11:44 am
AbbVie
Humira
Cyramza
Eli Lilly
generics
Evista
Cymbalta
Pfizer
Ibrance
Shire Deepens Push Into Biotech After AbbVie Drops Bid
WSJ Online
Mon, 07/13/15 - 07:33 pm
Shire
AbbVie
M&A
Fast-paced changes in drugs for hepatitis C seen as harbinger of rising US health care costs
Yahoo/AP
Sat, 07/11/15 - 10:20 am
drug pricing
hepatitis C
Harvoni
Sovaldi
AbbVie
Gilead Sciences
Viekira Pak
Gilead Sciences: Does Anyone Care About Hep-C Anymore?
Barron's
Fri, 07/10/15 - 01:43 pm
Gilead Sciences
hepatitis C
AbbVie
Harvoni
Sovaldi
Viekira Pak
Johnson & Johnson: Experimental drug clears more psoriasis patches than rival AbbVie's Humira
Yahoo/AP
Thu, 07/9/15 - 10:13 am
JNJ
AbbVie
psoriasis
guselkumab
Merck and Samsung's Humira biosimilar comes through in Phase III
Fierce Biotech
Wed, 07/8/15 - 09:23 am
Merck
Humira
biosimilars
SB5
Samsung Bioepis
AbbVie
rheumatoid arthritis
AbbVie has room to cut marketing spend if Humira biosims start hurting: analysts
Fierce Pharma Marketing
Wed, 07/1/15 - 12:09 pm
AbbVie
Humira
biosimilars
AbbVie hepatitis C cocktail succeeds in late-stage study
Reuters
Wed, 06/24/15 - 10:20 am
AbbVie
hepatitis C
Viekira Pak
Chi-Med Arthritis Drug Spurs Interest From Possible Partners
Bloomberg
Fri, 06/19/15 - 10:06 am
Chi-Med
HMPL-523
rheumatoid arthritis
Imbruvica
AbbVie
Bad news for AbbVie: Humira copies expected to rack up biggest biosim sales
Fierce Pharma
Tue, 06/16/15 - 12:15 pm
AbbVie
Humira
biosimilars
Pharmacyclics
AbbVie creates new position to expand global philanthropy
Bizjournals.com
Mon, 06/15/15 - 09:02 pm
philanthropy
AbbVie
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
24/7 Wall St
Mon, 06/8/15 - 09:58 pm
autoimmune disease
AbbVie
JNJ
Eli Lilly
Merck
Bristol-Myers Squibb
Pfizer

Pages